CRISPR Therapeutics AG (CRSP)
56.19
+0.52
(+0.93%)
USD |
NASDAQ |
May 17, 16:00
55.91
-0.28
(-0.50%)
After-Hours: 20:00
CRISPR Therapeutics Accounts Payable (Quarterly): 16.46M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 16.46M |
December 31, 2023 | 38.15M |
September 30, 2023 | 26.15M |
June 30, 2023 | 27.59M |
March 31, 2023 | 45.15M |
December 31, 2022 | 27.43M |
September 30, 2022 | 32.11M |
June 30, 2022 | 25.24M |
March 31, 2022 | 27.11M |
December 31, 2021 | 14.82M |
September 30, 2021 | 10.17M |
June 30, 2021 | 10.14M |
March 31, 2021 | 13.07M |
December 31, 2020 | 9.094M |
September 30, 2020 | 19.02M |
June 30, 2020 | 13.22M |
March 31, 2020 | 11.28M |
Date | Value |
---|---|
December 31, 2019 | 5.944M |
September 30, 2019 | 3.374M |
June 30, 2019 | 7.143M |
March 31, 2019 | 7.131M |
December 31, 2018 | 5.069M |
September 30, 2018 | 5.221M |
June 30, 2018 | 4.479M |
March 31, 2018 | 2.546M |
December 31, 2017 | 1.639M |
September 30, 2017 | 2.116M |
June 30, 2017 | 2.559M |
March 31, 2017 | 3.937M |
December 31, 2016 | 4.569M |
September 30, 2016 | 1.943M |
June 30, 2016 | 3.687M |
December 31, 2015 | 1.584M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
3.374M
Minimum
Sep 2019
45.15M
Maximum
Mar 2023
19.13M
Average
15.64M
Median
Accounts Payable (Quarterly) Benchmarks
Vertex Pharmaceuticals Inc | 351.40M |
Novartis AG | 4.062B |
Intellia Therapeutics Inc | 13.69M |
Regeneron Pharmaceuticals Inc | 671.30M |
Viking Therapeutics Inc | 5.225M |